Considerations for Neuroscience Trials with Intrathecal Delivery and Other Methods of Direct CNS Administration
XTalks
AUGUST 30, 2022
Clinical research experts from the CRO Medpace shared insights about the operational and regulatory considerations for neuroscience trials with direct CNS administration. The return of cell therapy-iPSCs (induced pluripotent stem cells) and genetically altered delivery cells. Reporter genes to understand dose and distribution.
83 
Let's personalize your content